Figure 10. K‐M analysis of survival using a Mito‐Signature in a group of ER(+) breast cancer. These patients were treated with hormonal therapy. Note that patients with high‐expression levels of the Mito‐ Signature showed a >3‐fold reduction in long‐term survival (N = 170 patients; p = 7.8e‐05). OS, overall survival.